Department of Pediatric Cardiology and Intensive Care Medicine, Georg August University Medical Center, Göttingen, Germany.
Department of Thoracic and Cardiac Surgery, Georg August University Medical Center, Göttingen, Germany.
Pacing Clin Electrophysiol. 2020 Dec;43(12):1481-1485. doi: 10.1111/pace.14067. Epub 2020 Sep 22.
Pacemaker used in small children typically consist of an abdominally placed generator and epicardially affixed leads, making such a system prone to lead dysfunction during growth. Aim of this study was to investigate the feasibility of epicardial pacing with a leadless pacemaker in a lamb model.
Seventeen lambs underwent epicardial implantation of a Micra transcatheter pacing system (TPS) (Medtronic, Minneapolis, MN, USA) via left-lateral thoracotomy to the left ventricle (LV) surface (n = 11/17) and to the left atrial appendage (n = 6). Ventricular devices were fixated with the tines within the pericardium, whereas the tines of the atrial devices penetrated the myocardium of the left atrial appendage. After 31 weeks, animals were sacrificed and hearts were explanted for histological analysis.
Following implantation, median P/R amplitude was 4.25/5.5 mV while median pacing threshold was 1.1/1.9 V at 0.24 ms. After 31 weeks, median P/R amplitude was 3.3/4.2 mV. Median atrial pacing threshold was 0.5/0.24 ms. Eight of 10 ventricular pacemakers had lost capture at standard impulse width even at maximum impulse amplitude. On explantation, firm adhesion of the device to the thoracic wall and dislodgement of the electrode tip was found in those ventricular devices.
Firm fixation of the Micra electrode to the epicardial surface as applied to the atrial devices resulted in excellent electrical properties during midterm follow up. Pericardial fixation as in the ventricular devices was associated with loss of capture. Therefore, it is important to embed the tines in the myocardium and to choose an alternative implantation site allowing for safe fixation of the Micra TPS in a position perpendicular to ventricular epimyocardium.
用于小儿的起搏器通常由腹部放置的发生器和心外膜附着的导线组成,使得这种系统在生长过程中容易出现导线功能障碍。本研究旨在探讨在羔羊模型中心外膜起搏使用无导线起搏器的可行性。
17 只羔羊通过左侧开胸术将 Micra 经导管起搏系统(TPS)(美敦力,明尼苏达州明尼阿波利斯)植入左心室(LV)表面(n=11/17)和左心耳(n=6)。心室设备的叉齿固定在心包内,而心房设备的叉齿穿透左心耳的心肌。31 周后,处死动物并取出心脏进行组织学分析。
植入后,中位 P/R 振幅为 4.25/5.5 mV,中位起搏阈值为 0.24 ms 时的 1.1/1.9 V。31 周后,中位 P/R 振幅为 3.3/4.2 mV。中位心房起搏阈值为 0.5/0.24 ms。即使在最大脉冲幅度下,10 个心室起搏器中的 8 个也失去了捕获。在取出时,发现那些心室设备的设备与胸壁牢固粘连,并且电极尖端移位。
如应用于心房设备,将 Micra 电极牢固固定于心外膜表面可在中期随访期间获得出色的电性能。与心室设备一样,心包固定与捕获丧失有关。因此,将叉齿嵌入心肌并选择允许 Micra TPS 在垂直于心室心外膜的位置安全固定的替代植入部位非常重要。